Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFa in an orthotopic liver transplant patient.

Details

Language :

English

ISSN :

18739946

Volume :

9

Issue :

9

Database :

Supplemental Index

Journal :

Journal of Crohn's & Colitis

Publication Type :

Academic Journal

Accession number :

116392489

Full Text :

https://doi.org/10.1093/ecco-jcc/jjv109